Dr. Richard Viscarello serves as the attending physician in the Department of Obstetrics and Gynecology at Stamford Hospital. He is also the president, chief executive officer and medical director of Maternal Fetal Care, PC in Stamford, Connecticut.
Dr. Viscarello is board certified in obstetrics and gynecology as well as maternal-fetal medicine, and has been providing OB/GYN care throughout the Connecticut community and beyond for over 40 years.
Having delivered more than 100 sets of triplets, 350+ sets of twins and countless singletons during his career, Dr. Viscarello is truly passionate about his work and is devoted to supporting each individual patient throughout her distinct pregnancy.
Dr. Viscarello has been awarded several honors and accolades noting his professional distinction, including:
- People’s Choice Award, Best Doctors in Connecticut
- Connecticut’s Best Doctors, Connecticut Magazine
- Irving Friedman, M.D. Award for Outstanding Clinical Abilities
Dr. Viscarello has been active in numerous professional organizations and has made significant contributions to the field of obstetrics and gynecology. He’s a committed investigator and collaborator on research projects that were awarded multi-million dollar grants from the National Institute of Drug Abuse and the National Institutes of Health. Additionally, he has authored more than 50 published manuscripts and book chapters.
As an advocate for the health of women and infants, he has served as a member and chairman of committees supporting substance-abusing women and their children, HIV and AIDS research, child health and development, and pediatric infectious diseases.
Bal AK, Miller G, Viscarello RR, Andiman WA. Syncytium-inhibiting and neutralizing activity in maternal sera fail to prevent vertical transmission of HIV-1. Pediat Infect Dis J. 15 (4): 315-20, 1996.
Van Dyke RB, Korber BT, Popek E, Macken C, Widmayer SM, Bardeguez A, Hanson IC, Wiznia A, Luzuriaga K, Viscarello RR, Wolinsky S, and the Ariel Core Investigators. The Ariel Project: A Prospective Cohort Study of Maternal-Child Transmission of Human Immunodeficiency Virus Type 1 in the Era of Maternal Antiretroviral Therapy. J Infect Dis. 179 (2): 319-28, 1999.
Wilson CC, Brown RC, Korber BT, Wilkes BM, Ruhl DJ, Sakamoto D, Kunstman K, Luzuriaga K, Hanson IC, Widmayer SM, Wiznia A, Clapp S, Ammann AJ, Koup RA, Wolinsky S, Walker BD, Viscarello RR, and the Ariel Project Investigators. Frequent Detection of Escape from Cytotoxic T-Lymphocyte Recognition in Perinatal HIV-1 Transmission: the Ariel Project for the Prevention of Transmission of HIV-1 from Mother to Infant. J Virol. 73 (5): 3975-3985, 1999.
The International Perinatal HIV Group. The Mode of Delivery and the Risk of Vertical Transmission of Human Immunodeficiency Virus Type I. N Engl J Med. 340: 977-87, 1999.
Cusick, W, Leuci D, Viscarello RR, Rodis JF. Anaphylactoid Syndrome of Pregnancy after Intracervical Dinoprostone for Cervical Ripening. J Reprod Med. 50:225-8, 2005.
Timor-Tritsch IE, Monteagudo A, Cali G, Dar P, Vintzileos A, Viscarello RR, Al-Khan A. Cesarean scar pregnancy is a precursor of morbidly adherent placenta. Ultrasound Obstet Gynecol. 2014 Sep;44(3):346-53.
Viscarello RR, Jenkins M, DeGennaro NJ, Kohl S. Relationship between antibody-dependent cellular cytotoxicity antibody titers and mother-to-child transmission of HIV-1. Poster presentation at the Annual Meeting of the Society for Gynecologic Investigation, San Antonio, TX, March 22-27, 1994, Abstract # P322.
Viscarello RR, Cullen MT, Delke I, Paryani S, DeGennaro NJ, Sanchez-Ramos L. Prenatal diagnosis of HIV-1 infection using cordocentesis, p24 antigen assay, and polymerase chain reaction. Poster presentation at the Annual Meeting of the Society for Gynecologic Investigation, San Antonio, TX, March 22-27, 1994, Abstract # P321.
Viscarello RR, Griffith SM, Prytherch MB, Baringer K. Outpatient Use of Intracervical Prostaglandin Gel is a Safe and Effective Method of Labor Induction. Poster presentation at the Annual Meeting of the Society for Maternal Fetal Medicine, Miami, FL, January 31-February 5, 2000. Abstract published in Am J Obstet Gynecol. 182 (1): S155, 2000.
Viscarello RR, Griffith SM, Jacques D, Charney LM, Prytherch MB. Perinatal Outcome After Multifetal Pregnancy Reduction. Poster presentation at the Annual Meeting of the Society for Maternal Fetal Medicine, New Orleans, LA, January 17-20, 2001. Abstract published in Am J Obstet Gynecol. 184 (1): S19, 2001.
Bornstein E, Mayberry P, Viscarello RR, Monteagudo A, Timor-Tritsch I. Partial and complete Trisomy 16: sonographic appearance and natural history. Abstract published in Ultrasound Obstet Gynecol. 36 (Suppl. 1): 304, 2010.
Chapters in Books
Schottenfeld RS, Grossman J, Viscarello RR. Treatment of Pregnant Addicts and Their Infants. National Institute on Drug Abuse Research Monograph 132 entitled “Problems of Drug Dependence,” Harris L, ed., 1993.
Grossman J, Schottenfeld RS, Viscarello RR, Pakes J. Cocaine Abuse During Pregnancy" National Institute on Drug Abuse Research Monograph 149 entitled “Medications Development for the Treatment of Pregnant Addicts,” Chaing CN and Finnegan LP, eds. 1995.
Elfarra J, Darby MM, Viscarello RR. HELLP Syndrome and the Liver: Hepatic Pathology, Hemorrhage, Rupture, and Failure. In: The 2015 Compendium for HELLP Syndrome: From Bench to Bedside. Martin JN, ed. Nova Science Publishers, Inc., 2015.
Elfarra J, Viscarello RR, Bean C, Di Renzo GC, Martin JN Jr. Hypertensive Disorders of Pregnancy. In: Management and Therapy of Early Pregnancy Complications. Malvasi et al (eds.) Springer International Publishing, 2016.